Instil Bio, Inc. is a biotechnology company focused on developing innovative cell therapies for the treatment of cancer

The company specializes in harnessing the power of tumor-infiltrating lymphocytes (TILs), a type of immune cell that has the potential to recognize and attack tumor cells. By utilizing advanced manufacturing processes and proprietary technologies, Instil Bio aims to create personalized treatment options tailored to the unique characteristics of each patient's cancer. Their research efforts are geared towards improving outcomes for patients suffering from various types of malignancies, with the goal of delivering safe and effective therapies that can ultimately enhance the quality of life.